RT Journal Article
SR Electronic
T1 Evolution during primary HIV infection does not require adaptive immune selection
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.07.20245480
DO 10.1101/2020.12.07.20245480
A1 David A Swan
A1 Morgane Rolland
A1 Joshua Herbeck
A1 Joshua T Schiffer
A1 Daniel B Reeves
YR 2020
UL http://medrxiv.org/content/early/2020/12/08/2020.12.07.20245480.1.abstract
AB Modern HIV research depends crucially on both viral sequencing and population measurements. To directly link mechanistic biological processes and evolutionary dynamics during HIV infection, we developed multiple within-host phylodynamic (wi-phy) models of HIV primary infection for comparative validation against viral load and evolutionary dynamics data. The most parsimonious and accurate model required no positive selection, suggesting that the host adaptive immune system reduces viral load, but does not drive observed viral evolution. Rather, random genetic drift primarily dictates fitness changes. These results hold during early infection, and even during chronic infection when selection has been observed, viral fitness distributions are not largely different from in vitro distributions that emerge without adaptive immunity. These results highlight how phylogenetic inference must consider complex viral and immune-cell population dynamics to gain accurate mechanistic insights.One sentence summary Through the lens of a unified population and phylodynamic model, current data show the first wave of HIV mutations are not driven by selection by the adaptive immune system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by a WRF postdoctoral fellowship and an NIAID K25 to DBR.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data are taken from published studies in which IRB oversight was performed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from previous studies and model code is freely available upon request.